These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 19088036)

  • 81. Use of Affymetrix Arrays in the Diagnosis of Gene Copy-Number Variation.
    Zahir FR; Marra MA
    Curr Protoc Hum Genet; 2015 Apr; 85():8.13.1-8.13.13. PubMed ID: 25827348
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Non-muscle-invasive bladder cancer surveillance for which cystoscopy is partly replaced by microsatellite analysis of urine: a cost-effective alternative?
    de Bekker-Grob EW; van der Aa MN; Zwarthoff EC; Eijkemans MJ; van Rhijn BW; van der Kwast TH; Steyerberg EW
    BJU Int; 2009 Jul; 104(1):41-7. PubMed ID: 19500328
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Segmentation-based detection of allelic imbalance and loss-of-heterozygosity in cancer cells using whole genome SNP arrays.
    Staaf J; Lindgren D; Vallon-Christersson J; Isaksson A; Göransson H; Juliusson G; Rosenquist R; Höglund M; Borg A; Ringnér M
    Genome Biol; 2008; 9(9):R136. PubMed ID: 18796136
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Recurrence at three months and high-grade recurrence as prognostic factor of progression in multivariate analysis of T1G2 bladder tumors.
    Palou J; Rodríguez-Rubio F; Millán F; Algaba F; Rodríguez-Faba O; Huguet J; Villavicencio H
    Urology; 2009 Jun; 73(6):1313-7. PubMed ID: 19362341
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Risk of concomitant carcinoma in situ determining biopsy candidates among primary non-muscle-invasive bladder cancer patients: retrospective analysis of 173 Japanese cases.
    Hara T; Takahashi M; Gondo T; Nagao K; Ohmi C; Sakano S; Naito K; Matsuyama H
    Int J Urol; 2009 Mar; 16(3):293-8. PubMed ID: 19207607
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Affymetrix GeneChip system: moving from research to the clinic.
    Ragoussis J; Elvidge G
    Expert Rev Mol Diagn; 2006 Mar; 6(2):145-52. PubMed ID: 16512775
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Use of Affymetrix mapping arrays in the diagnosis of gene copy number variation.
    Delaney AD; Qian H; Friedman JM; Marra MA
    Curr Protoc Hum Genet; 2008 Oct; Chapter 8():Unit 8.13. PubMed ID: 18972373
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Getting more from digital SNP data.
    El Karoui N; Zhou W; Whittemore AS
    Stat Med; 2006 Sep; 25(18):3124-33. PubMed ID: 16397858
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Alpha-T-catenin (CTNNA3) displays tumour specific monoallelic expression in urothelial carcinoma of the bladder.
    Meehan M; Melvin A; Gallagher E; Smith J; McGoldrick A; Moss C; Goossens S; Harrison M; Kay E; Fitzpatrick J; Dervan P; Mc Cann A
    Genes Chromosomes Cancer; 2007 Jun; 46(6):587-93. PubMed ID: 17366617
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Nuclear matrix protein 22 as adjunct to urine cytology and cystoscopy in follow-up of superficial TCC of urinary bladder.
    Gupta NP; Sharma N; Kumar R
    Urology; 2009 Mar; 73(3):592-6; discussion 596-7. PubMed ID: 19168205
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Detection of tumours of the urinary tract in voided urine.
    Zwarthoff EC
    Scand J Urol Nephrol Suppl; 2008 Sep; (218):147-53. PubMed ID: 18815929
    [TBL] [Abstract][Full Text] [Related]  

  • 92. CARAT: a novel method for allelic detection of DNA copy number changes using high density oligonucleotide arrays.
    Huang J; Wei W; Chen J; Zhang J; Liu G; Di X; Mei R; Ishikawa S; Aburatani H; Jones KW; Shapero MH
    BMC Bioinformatics; 2006 Feb; 7():83. PubMed ID: 16504045
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Allelic alterations in pancreatic endocrine tumors identified by genome-wide single nucleotide polymorphism analysis.
    Nagano Y; Kim DH; Zhang L; White JA; Yao JC; Hamilton SR; Rashid A
    Endocr Relat Cancer; 2007 Jun; 14(2):483-92. PubMed ID: 17639061
    [TBL] [Abstract][Full Text] [Related]  

  • 94. A fast and accurate method to detect allelic genomic imbalances underlying mosaic rearrangements using SNP array data.
    González JR; Rodríguez-Santiago B; Cáceres A; Pique-Regi R; Rothman N; Chanock SJ; Armengol L; Pérez-Jurado LA
    BMC Bioinformatics; 2011 May; 12():166. PubMed ID: 21586113
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Editorial comment on: Microsatellite analysis of voided-urine samples for surveillance of low-grade non-muscle-invasive urothelial carcinoma: feasibility and clinical utility in a prospective multicenter study (Cost-Effectiveness of Follow-Up of Urinary Bladder Cancer trial CEFUB).
    van der Poel HG
    Eur Urol; 2009 Mar; 55(3):667-8. PubMed ID: 18501500
    [No Abstract]   [Full Text] [Related]  

  • 96. Somatic Mutation Allelic Ratio Test Using ddPCR (SMART-ddPCR): An Accurate Method for Assessment of Preferential Allelic Imbalance in Tumor DNA.
    de Smith AJ; Walsh KM; Hansen HM; Endicott AA; Wiencke JK; Metayer C; Wiemels JL
    PLoS One; 2015; 10(11):e0143343. PubMed ID: 26575185
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Clinical utility of single nucleotide polymorphism arrays.
    Schwartz S
    Clin Lab Med; 2011 Dec; 31(4):581-94, viii. PubMed ID: 22118738
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Resolution of trisomic mosaicism in prenatal diagnosis: estimated performance of a 50K SNP microarray.
    Cross J; Peters G; Wu Z; Brohede J; Hannan GN
    Prenat Diagn; 2007 Dec; 27(13):1197-204. PubMed ID: 17994637
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Assessment of plasma DNA levels, allelic imbalance, and CA 125 as diagnostic tests for cancer.
    Chang HW; Lee SM; Goodman SN; Singer G; Cho SK; Sokoll LJ; Montz FJ; Roden R; Zhang Z; Chan DW; Kurman RJ; Shih IeM
    J Natl Cancer Inst; 2002 Nov; 94(22):1697-703. PubMed ID: 12441325
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Validation of a protein panel for the noninvasive detection of recurrent non-muscle invasive bladder cancer.
    Gogalic S; Sauer U; Doppler S; Heinzel A; Perco P; Lukas A; Simpson G; Pandha H; Horvath A; Preininger C
    Biomarkers; 2017 Nov; 22(7):674-681. PubMed ID: 28010124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.